A single-item screening question for fear of recurrence in head and neck cancer
| Autor: | Simon N. Rogers, Ben Cross, Gerald Michael Humphris, Derek Lowe, Cyrus Talwar |
|---|---|
| Přispěvatelé: | University of St Andrews. School of Medicine, University of St Andrews. WHO Collaborating Centre for International Child & Adolescent Health Policy, University of St Andrews. St Andrews Sustainability Institute, University of St Andrews. Health Psychology |
| Rok vydání: | 2015 |
| Předmět: |
Male
medicine.medical_specialty NDAS Poison control R Medicine Anxiety UW-QOL Occupational safety and health 03 medical and health sciences 0302 clinical medicine SDG 3 - Good Health and Well-being Quality of life Surveys and Questionnaires Fear of recurrence Injury prevention medicine Humans Health related quality of life Survivors 030212 general & internal medicine Head and neck cancer Patient reported outcomes Aged Squamous Cell Carcinoma of Head and Neck business.industry Disease Management Fear General Medicine Middle Aged medicine.disease United Kingdom Cross-Sectional Studies Mood Otorhinolaryngology Head and Neck Neoplasms 030220 oncology & carcinogenesis Carcinoma Squamous Cell Quality of Life Physical therapy Female Neoplasm Recurrence Local medicine.symptom business |
| Zdroj: | European Archives of Oto-Rhino-Laryngology. 273:1235-1242 |
| ISSN: | 1434-4726 0937-4477 |
| DOI: | 10.1007/s00405-015-3585-x |
| Popis: | Background: Fear of recurrence (FoR) is the most frequent concern patients wish to discuss in head and neck review clinics. Aim: To design a simple screening question on fear of recurrence to be incorporated into the University of Washington Quality of Life Questionnaire (UW-QOLv4), for use in clinical practice. Methods: A cross-sectional survey comprising 528 patients. Results: 11% selected the two most severe FoR categories. FoR responses correlated strongly (Spearman rs=-0.82) with the mean score of the 7 items of the Fear of Recurrence Questionnaire. There was also a strong association with anxiety and mood dysfunction as measured from the UW-QOL, and with overall QOL. Patients more affected by FoR tended to be younger and post radiotherapy or chemotherapy. Conclusion: The FoR screening question should be bolted on to the UW-QOLv4 in order to help identify patients with significant FoR might benefit from further intervention. Postprint |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink